Eurofins Scientific SE (LON:0MV5)
59.60
+0.12 (0.19%)
At close: Jun 23, 2025
Eurofins Scientific SE Revenue
In the year 2024, Eurofins Scientific SE had annual revenue of 6.95B EUR with 6.70% growth. Eurofins Scientific SE had revenue of 3.53B in the half year ending December 31, 2024, with 7.02% growth.
Revenue
6.95B EUR
Revenue Growth
+6.70%
P/S Ratio
1.60
Revenue / Employee
110.87K EUR
Employees
62,696
Market Cap
9.20B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.95B | 436.40M | 6.70% |
Dec 31, 2023 | 6.51B | -197.50M | -2.94% |
Dec 31, 2022 | 6.71B | -5.60M | -0.08% |
Dec 31, 2021 | 6.72B | 1.28B | 23.51% |
Dec 31, 2020 | 5.44B | 876.00M | 19.20% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
HSBC Holdings | 44.89B |
Shell | 217.54B |
Unilever | 50.25B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |
RELX PLC | 9.43B |
Rio Tinto Group | 42.86B |